Annals of Allergy, Asthma & Immunology
Annals of Allergy, Asthma & Immunology is a peer-reviewed medical journal that focuses on the research, diagnosis, and treatment of allergic and immunologic diseases. The journal serves as a vital resource for clinicians, researchers, and healthcare professionals involved in the care of patients with allergic and immunologic disorders. It publishes original articles, reviews, and case reports that contribute to the understanding, management, and treatment of allergies, asthma, and immune system disorders.
Overview[edit | edit source]
The journal covers a wide range of topics related to allergy, asthma, and immunology, including but not limited to the pathophysiology, diagnosis, and management of these conditions. It also explores the latest advancements in immunotherapy, environmental triggers of allergic and immunologic diseases, and the genetic basis of these conditions. The Annals of Allergy, Asthma & Immunology aims to disseminate cutting-edge research and practical clinical information to improve patient care.
History[edit | edit source]
The Annals of Allergy, Asthma & Immunology was established to fill the need for a comprehensive resource on the rapidly evolving fields of allergy and immunology. Over the years, it has grown in scope and stature, becoming a leading journal in its field. The journal is the official publication of the American College of Allergy, Asthma & Immunology (ACAAI), a professional association dedicated to advancing the field of allergy and immunology for optimal patient care.
Publication Frequency[edit | edit source]
The journal is published monthly, providing timely updates on the latest research and clinical practices. Each issue includes a mix of original research articles, review articles, clinical case reports, and editorials that address the most pressing topics in allergy, asthma, and immunology.
Editorial Board[edit | edit source]
The editorial board of the Annals of Allergy, Asthma & Immunology consists of leading experts in the field of allergy and immunology. These professionals oversee the peer review process, ensuring that only high-quality, scientifically rigorous articles are published. The board also guides the journal's editorial direction, selecting topics of current interest and importance for special issues and features.
Access and Distribution[edit | edit source]
The journal is available in both print and online formats. Access to the full text of articles is available through subscription, with many institutions and libraries providing access to their members. The online platform offers advanced search features, allowing users to easily locate articles of interest. Additionally, selected articles and abstracts are made available for free, promoting wider access to important research findings.
Impact Factor[edit | edit source]
The Annals of Allergy, Asthma & Immunology has a respectable impact factor, reflecting its influence and importance in the field of allergy and immunology. The impact factor is a measure of the frequency with which the average article in a journal has been cited in a particular year, serving as an indicator of the journal's academic and clinical relevance.
Submission Guidelines[edit | edit source]
Researchers and clinicians interested in contributing to the Annals of Allergy, Asthma & Immunology are encouraged to review the submission guidelines available on the journal's website. The guidelines detail the types of manuscripts accepted, formatting requirements, and the peer review process. Submissions are accepted through an online submission system, streamlining the process for authors.
Conclusion[edit | edit source]
The Annals of Allergy, Asthma & Immunology plays a crucial role in the dissemination of knowledge and the advancement of research in the fields of allergy and immunology. Its comprehensive coverage of the latest developments, combined with its commitment to high-quality, peer-reviewed research, makes it an essential resource for professionals and researchers in these disciplines.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD